Diagnostic value of contrast enhancement of multi-slice helical CT in breast lesions
Xiaoling Lü
Abstract
Xiaoling Lü
Abstract
Objective:To evaluate contrast enhancement of multi-slice helical CT in differentiating benign breast lesions from malignant breast lesions.Methods:The subject were 84 patients with 93 breast lesions confirmed by pathology, including invasive ductal carcinoma(n=57),mucous carcinoma(n=4),fibroadenoma(n=13),intraductal papilloma(n=4) and other benign lesions(n=15).Following plain CT scanning,two phases enhanced scanning was initiated respectively at 28 and 90 second after contrast agent injection.Compared with histopathologic results,the CT findings of all breast lesions were analyzed.Results:There was no statistical significant difference between malignant and benign group in the density of mass on non-contrast phase(P0.05).There was statistical difference between the benign and the malignant group in the shape,edge,and enhancement pattern of mass(P=1.57×10~(-4);P=1.75×10~(-28);P=1.78×10~(-2)).Regarding a lesion with an enhancement of 25HU or more on the arterial contrast phase as a criterion,there is a statistical significant difference between breast malignant and benign lesions(P0.001).MSCT had a sensitivity of 96.7%,a specificity of 90.6%,a positive predictive value of 95.2%,and a negative predictive value of 93.5% in differentiating between benign and malignant breast masses.88.8% axillary lymph node metastasis could be preoperatively detected by MSCT.Conclusion:Contrast enhancement of multi-slice helical CT is of great value in differentiating benign from malignant breast lesions.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To evaluate contrast enhancement of multi-slice helical CT in differentiating benign breast lesions from malignant breast lesions.Methods:The subject were 84 patients with 93 breast lesions confirmed by pathology, including invasive ductal carcinoma(n=57),mucous carcinoma(n=4),fibroadenoma(n=13),intraductal papilloma(n=4) and other benign lesions(n=15).Following plain CT scanning,two phases enhanced scanning was initiated respectively at 28 and 90 second after contrast agent injection.Compared with histopathologic results,the CT findings of all breast lesions were analyzed.Results:There was no statistical significant difference between malignant and benign group in the density of mass on non-contrast phase(P0.05).There was statistical difference between the benign and the malignant group in the shape,edge,and enhancement pattern of mass(P=1.57×10~(-4);P=1.75×10~(-28);P=1.78×10~(-2)).Regarding a lesion with an enhancement of 25HU or more on the arterial contrast phase as a criterion,there is a statistical significant difference between breast malignant and benign lesions(P0.001).MSCT had a sensitivity of 96.7%,a specificity of 90.6%,a positive predictive value of 95.2%,and a negative predictive value of 93.5% in differentiating between benign and malignant breast masses.88.8% axillary lymph node metastasis could be preoperatively detected by MSCT.Conclusion:Contrast enhancement of multi-slice helical CT is of great value in differentiating benign from malignant breast lesions.
Key concepts: Medicine, Fibroadenoma, Radiology, Intraductal papilloma, Lesion, Mammography, Breast Fibroadenoma, Metastasis